Biotech startup to fight diabetes on the cellular front – Boston Globe (subscription)
Boston Globe (subscription) |
Biotech startup to fight diabetes on the cellular front
Boston Globe (subscription) Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Semma Secures $44M to Develop Diabetes Stem Cell Therapy Diabetes startup rakes in $44M and teams up with Novartis on cell therapy Semma Therapeutics Announces $44 Million in Funding Led by MPM Capital to … |
